Patents Assigned to SYNART CO., LTD.
  • Publication number: 20220056458
    Abstract: Provided is a technique for synthesizing a nicotinamide derivative (NAm derivative) such as a nicotinamide mononucleotide (NMN) with high efficiency. A genetically modified microorganism is used, which can express, as nicotinamide phosphoribosylt ransferase (NAMPT), NAMPT having a conversion efficiency of 5-folds or more that of human NAMPT.
    Type: Application
    Filed: December 17, 2019
    Publication date: February 24, 2022
    Applicants: TEIJIN LIMITED, SYNART CO., LTD.
    Inventors: Shinichiro SHOJI, Jun ISHII, Akihiko KONDO, Hidekazu WATANABE, Masanobu KANOU, Ryota NAKAJIMA